In this regular feature, Bulletproof interviews top plaintiffs’ attorneys for their perspective on the crises likely to affect businesses in the near future. Today we talk to Frank P. DiPrima of the Law Office of Frank DiPrima in Morristown, NJ. Mr. DiPrima has been co-counsel in the derivative law suit against Richard Scrushy, founder of HealthSouth Corporation. In its June, 2009, decision in Wade Tucker v Richard Scrushy et al., an Alabama court awarded plaintiffs $2.876 ... Read More

Yesterday's Supreme Court ruling that state regulators can take national banks to court in order to enforce state consumer protection laws is yet another blow to the principle of “preemption.” For those non-constitutional law scholars out there, preemption is the means by which federal law supersedes state law when contradictions between the two arise. In this case, New York Attorney General Andrew Cuomo and his predecessor Eliot Spitzer sought to enforce state consumer protection laws against ... Read More

Each week, Bulletproof Blog features exclusive interviews with thought leaders on issues of critical importance to companies and countries. This week, on the heels of the National Retail Federation’s (NRF) Loss Prevention Conference and EXPO, we interview Ellen Davis, NRF Vice President of Industry Public Relations. During her tenure at NRF, Ms. Davis has been responsible for evaluating NRF positions on a variety of retail topics including e-commerce, consumer spending, the economy, and loss prevention. A ... Read More

Last week, I had the pleasure of speaking at the National Retail Federation’s Loss Prevention Conference in Los Angeles – and if one point was driven home for me more than any other, it’s that retailers operate in an almost perpetual state of crisis. During my session with NRF Communications Vice President Ellen Davis, and in the conversations I had with conference participants throughout the week, I was reminded of the kinds of challenges that businesses ... Read More

This summer, the energy industry stands at a crossroads. The global warming debate is all-but decided. Another summer of surging prices is likely on the horizon. Action in Washington on myriad energy issues seems like a forgone conclusion.   In this month’s edition of Levick’s e-newsletter, High Stakes™, we examine the foremost communications challenges facing four pillars of the energy industry -- when what they do next may very well define their roles in America’s energy future. At ... Read More

The FDA is at it again. The latest product to fall victim to the newly-energized agency is Zicam, an over-the-counter cold and allergy product that some users claim has damaged their sense of smell. Unlike prescription drugs, over-the-counter remedies like Zicam don’t require FDA approval before they go on the market. But since 2007, companies have been required to report what are called “adverse events” related to their products. After the agency spotted the Zicam complaints ... Read More